GE

Stemgent completes acquisition of Asterand’s human tissue business

Wednesday, August 1, 2012 11:03 AM

Stemgent, a Cambridge, Mass.-based developer of proprietary tools and services focused on the application of human cells, has completed the acquisition of Asterand’s human tissue business for $9 million.

More... »

Gentris collaborates on blood stability

Thursday, July 26, 2012 03:29 PM

Gentris, a provider of pharmacogenomics and biorepository solutions, will begin a collaborative study with a major pharmaceutical company to test the long-term stability of DNA in whole blood samples that have been stored for five and 10 years.

More... »

GE Healthcare and iBio form new global alliance

Thursday, July 26, 2012 02:34 PM

GE Healthcare and iBio, a Newark, Del.-based provider of pharmaceutical product applications, have formed a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.

More... »

PRA participates in landmark Alzheimer’s prevention trial

Thursday, July 26, 2012 09:52 AM

PRA, a global CRO, is participating in an Alzheimer’s disease study that could lead to treatments delaying or even preventing the emergence of symptoms in people destined to develop the disease because of their genetic background.

More... »

Genentech and Novartis rank as image leaders among oncologists, hematologists

Wednesday, July 25, 2012 09:59 AM

Genentech and Novartis have the best image among oncologists and hematologists, according to Market Strategies International, a market research consultancy that recently completed its 2012 Oncology Image Study.

More... »

Boehringer Ingelheim acquires Funxional's FX125L and somatotaxin portfolio

Monday, July 23, 2012 03:49 PM

Boehringer Ingelheim has agreed to acquire global rights to Funxional Therapeutics’ FX125L compound and somatotaxin program.

More... »

Cell Medica secures $26.5M to establish U.S. operations and fund cell therapy development

Monday, July 23, 2012 03:04 PM

Cell Medica, a London-based cell therapeutics company, has secured a $26.5 million equity investment to launch new operations in Texas focusing on cancer immunotherapy and to continue development of its immune reconstitution cell therapies in Europe.

More... »

Biogen Idec to collaborate to sequence genomes of ALS patients

Tuesday, July 17, 2012 02:54 PM

Biogen Idec has entered into a research collaboration with premier academic and research institutions to sequence the genomes of up to 1,000 patients with amyotrophic lateral sclerosis (ALS) in an effort to gain a deeper understanding about the fundamental genetic causes of ALS.

More... »

BioStorage Technologies to strategically expand into Asia Pacific

Tuesday, July 17, 2012 12:09 PM

Indianapolis-based BioStorage Technologies, a provider of comprehensive sample management solutions for the bioscience industry, is expanding its services to the Asia Pacific region. The expansion includes the appointment of Jason Huang as general manager of Asia Pacific. 

More... »

GSK to acquire Human Genome Sciences for $14.25 per share in cash

Monday, July 16, 2012 10:51 AM

GlaxoSmithKline and Human Genome Sciences have announced a definitive agreement under which GSK will acquire HGS for $14.25 per share in cash.

More... »